Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina.

Autor: Ray EM; Department of Medicine, Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America., Teal RW; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Connected Health Applications and Interventions Core, University of North Carolina, Chapel Hill, North Carolina, United States of America., Carda-Auten J; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Connected Health Applications and Interventions Core, University of North Carolina, Chapel Hill, North Carolina, United States of America., Coffman E; Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America., Sanoff HK; Department of Medicine, Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2023 Jun 22; Vol. 18 (6), pp. e0287338. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).
DOI: 10.1371/journal.pone.0287338
Abstrakt: Background: Many patients with hepatocellular carcinoma (HCC) never receive cancer-directed therapy. In order to tailor interventions to increase access to appropriate therapy, we sought to understand the barriers and facilitators to HCC care.
Methods: Patients with recently diagnosed HCC were identified through the University of North Carolina (UNC) HCC clinic or local hospital cancer registrars (rapid case ascertainment, RCA). Two qualitative researchers conducted in-depth, semi-structured interviews. Interviews were audiotaped, transcribed, and coded.
Results: Nineteen interviews were conducted (10 UNC, 9 RCA). Key facilitators of care were: physician knowledge; effective communication regarding test results, plan of care, and prognosis; social support; and financial support. Barriers included: lack of transportation; cost of care; provider lack of knowledge about HCC; delays in scheduling; or poor communication with the medical team. Participants suggested better coordination of appointments and having a primary contact within the healthcare team.
Limitations: We primarily captured the perspectives of those HCC patients who, despite the challenges they describe, were ultimately able to receive HCC care.
Conclusions: This study identifies key facilitators and barriers to accessing care for HCC in North Carolina. Use of the RCA system to identify patients from a variety of settings, treated and untreated, enabled us to capture a broad range of perspectives. Reducing barriers through improving communication and care coordination, assisting with out-of-pocket costs, and engaging caregivers and other medical providers may improve access. This study should serve as the basis for tailored interventions aimed at improving access to appropriate, life-prolonging care for patients with HCC.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2023 Ray et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje